JNJ vs CAH
By Alex · Tickerpine
Johnson & Johnson vs Cardinal Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | CAH |
|---|---|---|
| Price | $254.66 | $237.92 |
| Market cap | $613.02B | $55.72B |
| P/E ratio | 29.5 | 36.4 |
| ROE | 26.42% | — |
| Profit margin | 21.83% | 0.62% |
| Revenue growth | 9.90% | 11.00% |
| Dividend yield | 2.10% | 0.86% |
| Beta | 0.26 | 0.53 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs CAH in plain English
- JNJ is the bigger company — about 11.0× the market cap of CAH.
- JNJ is cheaper on earnings (P/E 29.5 vs 36.4).
- CAH is growing revenue faster (11% vs 10%).
- JNJ has the higher dividend yield (2.10% vs 0.86%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
CAH return calculator
See what $1,000 in Cardinal Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.